Product Code: ETC089533 | Publication Date: Jul 2023 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
The Tunisia antiparasitics drugs market is expected to grow at a CAGR of around 8.4% during the forecast period 2020-2025. The growth of the market can be attributed to several factors such as increasing prevalence of vector borne diseases, rising awareness about preventive measures for contagious diseases, and growing demand for pet healthcare products in the country.
The increasing prevalence of vector borne diseases due to climate change has been one of the major drivers for the Tunisia antiparasitics drugs market growth. Vector-borne infections are projected to increase by up to 20 times till 2050 due to global warming which would lead an increased requirement in veterinary treatments and medicines across Tunisia. Moreover, rising awareness about preventive measures for contagious diseases is expected to drive the demand further over the forecast period 2020-2025. Furthermore, growing animal companion culture among people all over Tunisia has increased expenditure on pet healthcare products such as parasitic remedies leading towards a surge in demand and growth prospects for this industry in recent years.
Despite numerous positive aspects associated with antiparasitics drugs use, there are certain challenges that may hinder its sales outlook throughout 2025; some major ones being lack of availability or accessibility at local stores coupled with high cost associated with many branded products particularly those containing new active ingredients & having advanced drug delivery systems (DDD). Additionally, lack of knowledge regarding proper usage & dosage recommendations among people living in rural areas could also limit their adoption rate within these regions consequently affecting overall industry progress negatively.
Major players operating within Tunisian Antiparasitic Drugs Market include Novartis Animal Health Inc., Merck Animal Health (Merial SNC), Boehringer Ingelheim GmbH., Elanco Corporation , Virbac SA , Bayer AG , Zoetis Inc., Sanofi Aventis Group etc.) . These companies have established strong foothold through development & launch novel product lines catering specific disease conditions along with business expansions undertaken via mergers/acquisitions & collaborations enabling them gain competitive edge over other participants present within same segment space globally.
Due to COVID19 outbreak pandemic situation prevailing globally since early 2020 series lockdowns have been imposed which resulted into temporary closure retail outlets including veterinary clinics thus adversely impacting according sales volume figures currently witnessed from this sector during current year
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Tunisia Antiparasitics Drugs Market Overview |
3.1 Tunisia Country Macro Economic Indicators |
3.2 Tunisia Antiparasitics Drugs Market Revenues & Volume, 2020 & 2027F |
3.3 Tunisia Antiparasitics Drugs Market - Industry Life Cycle |
3.4 Tunisia Antiparasitics Drugs Market - Porter's Five Forces |
3.5 Tunisia Antiparasitics Drugs Market Revenues & Volume Share, By Route of Administration, 2020 & 2027F |
3.6 Tunisia Antiparasitics Drugs Market Revenues & Volume Share, By Drug class, 2020 & 2027F |
3.7 Tunisia Antiparasitics Drugs Market Revenues & Volume Share, By Distribution Channel, 2020 & 2027F |
4 Tunisia Antiparasitics Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Tunisia Antiparasitics Drugs Market Trends |
6 Tunisia Antiparasitics Drugs Market, By Types |
6.1 Tunisia Antiparasitics Drugs Market, By Route of Administration |
6.1.1 Overview and Analysis |
6.1.2 Tunisia Antiparasitics Drugs Market Revenues & Volume, By Route of Administration, 2018 - 2027F |
6.1.3 Tunisia Antiparasitics Drugs Market Revenues & Volume, By Oral, 2018 - 2027F |
6.1.4 Tunisia Antiparasitics Drugs Market Revenues & Volume, By Injectable, 2018 - 2027F |
6.1.5 Tunisia Antiparasitics Drugs Market Revenues & Volume, By Topical, 2018 - 2027F |
6.2 Tunisia Antiparasitics Drugs Market, By Drug class |
6.2.1 Overview and Analysis |
6.2.2 Tunisia Antiparasitics Drugs Market Revenues & Volume, By Anthelmintics, 2018 - 2027F |
6.2.3 Tunisia Antiparasitics Drugs Market Revenues & Volume, By Antiprotozoals, 2018 - 2027F |
6.2.4 Tunisia Antiparasitics Drugs Market Revenues & Volume, By Others, 2018 - 2027F |
6.3 Tunisia Antiparasitics Drugs Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Tunisia Antiparasitics Drugs Market Revenues & Volume, By Hospital Pharmacies, 2018 - 2027F |
6.3.3 Tunisia Antiparasitics Drugs Market Revenues & Volume, By Retail Pharmacies, 2018 - 2027F |
6.3.4 Tunisia Antiparasitics Drugs Market Revenues & Volume, By Online Pharmacies, 2018 - 2027F |
7 Tunisia Antiparasitics Drugs Market Import-Export Trade Statistics |
7.1 Tunisia Antiparasitics Drugs Market Export to Major Countries |
7.2 Tunisia Antiparasitics Drugs Market Imports from Major Countries |
8 Tunisia Antiparasitics Drugs Market Key Performance Indicators |
9 Tunisia Antiparasitics Drugs Market - Opportunity Assessment |
9.1 Tunisia Antiparasitics Drugs Market Opportunity Assessment, By Route of Administration, 2020 & 2027F |
9.2 Tunisia Antiparasitics Drugs Market Opportunity Assessment, By Drug class, 2020 & 2027F |
9.3 Tunisia Antiparasitics Drugs Market Opportunity Assessment, By Distribution Channel, 2020 & 2027F |
10 Tunisia Antiparasitics Drugs Market - Competitive Landscape |
10.1 Tunisia Antiparasitics Drugs Market Revenue Share, By Companies, 2020 |
10.2 Tunisia Antiparasitics Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |